Ace Therapeutics is a specialist in the development of drugs for liver disease. We provide professional and high-quality research services for all aspects of liver disease drug development.
Preclinical drug evaluation plays a pivotal role in determining whether a new drug can enter clinical studies, predicting the level of risk in clinical studies and ultimately evaluating the development value of a drug candidate. Therefore, preclinical studies are of great importance for drug development. We provide comprehensive preclinical drug evaluation services for liver disease drugs.
What Can We Do?
An advanced and comprehensive preclinical drug evaluation platform is critical to the development and study of drugs for liver disease. We provide a quality preclinical drug evaluation platform for liver disease drug development platform for the comprehensive evaluation of drug candidates.
The therapeutic effect of a drug is an important indicator to judge the value of a drug candidate. The in vitro and in vivo evaluation of drugs provides a more comprehensive understanding of the therapeutic effect of drugs on liver disease. This helps to further evaluate whether the drug candidate is of value for research only.
- We provide a comprehensive platform for evaluating drug efficacy in liver disease. This includes liver disease model construction, liver injury pathology testing, biomarker detection and analysis, and other testing services.
The purpose of preclinical pharmacokinetic studies is to elucidate the processes and characteristics of absorption, distribution, metabolism, and excretion of drug candidates in vivo. It also provides some important pharmacokinetic parameters, which in turn reveal the dynamic regularity of the new drug in vivo, such as the rate and extent of absorption; the distribution of the drug throughout the body, the plasma protein binding rate of the drug; the elucidation of the structure of the metabolite, the transformation pathway and its kinetics; the pathway, rate and excretion amount of excretion.
- In view of the important role of preclinical pharmacokinetics in the drug development process, we offer a comprehensive pharmacokinetic study service.
The main objectives of preclinical drug safety evaluation are to determine safe starting doses for human use and subsequent dose escalation regimens, to identify potentially toxic target organs and study whether such toxicity is reversible, and to determine safety parameters for clinical monitoring. The safety and efficacy of a drug are determining factors in the success of drug development, and the safety of a drug, i.e., drug toxicity, is one of the most important reasons for terminating drug development throughout the drug development process. The liver is even more important for the metabolism of drugs. Therefore, a comprehensive and quality drug safety evaluation is needed for drugs targeting liver disease.
- We provide high-quality and comprehensive research services for preclinical drug safety evaluation of liver disease drugs to ensure the safety of drug candidates.
Drug formulation research is the design and optimization of drug candidate formulations through comprehensive testing and research on the properties of the drug candidate, combined with the specific effects of the drug candidate and delivery routes. A good drug formulation can make the drug work more fully and achieve better therapeutic purposes.
- We provide a variety of process and optimization technologies for preclinical drug formulation studies to assist in the development of drugs for liver diseases through our integrated services.
Ace Therapeutics provides quality drug development services for liver disease. Our services cover the entire process of drug development and can solve the worries of liver disease drug developers. If you would like to learn more about our services, please feel free to contact us.
Related Services
Our products and services are for research use only and can not be used for diagnostic or other purposes.
